LARGE-SCALE CLINICAL AND POPULATION-BASED RESEARCH
Professor Christopher Reid,
Cardiovascular Epidemiologist & Research Professor, School of Public Health & Preventive Medicine, Monash University, Victoria, Australia & School of Population Health at Curtin University, Western Australia & Chair, Australian Clinical Trials Alliance (ACTA)
RESEARCHER PROFILE
Filmed in Perth, Australia | October 2026
Christopher Reid is an internationally renowned cardiovascular epidemiologist with appointments as a Research Professor in both the School of Population Health at Curtin University and the School of Public Health and Preventive Medicine, at Monash University.
He was re-appointed as a John Curtin Distinguished Professor in 2021 and is currently Director of the Monash and Curtin Centre for Clinical Research and Education (CCRE). He has been awarded over $178M as a Chief Investigator and has received continuous NHMRC funding since 2001.
His major research interests include clinical outcome registries, randomised controlled trials, and epidemiological cohort studies. He has over 820 peer-reviewed publications (with over 44000 citations and a H-Index of 91) many of which are in leading journals including the New England Journal of Medicine, the Lancet, JAMA, JACC, and the BMJ.
He is a Chief Investigator for the Colchicine in Type 2 diabetes trial (COLCOT-T2D), the Aspirin in the Elderly (ASPREE) trial, the HOPE-3 trial, the Statins in Reducing Events in the Elderly (STAREE) trial and the LEADER-PAD trial. He is also the research director for the Australian and New Zealand Cardiothoracic database (ANZSCTS) registry and the Victorian Cardiac Outcomes registry (VCOR).
He is the Board Chair of the Australian Clinical Trials Alliance (ACTA) and a board member of the Australian New Zealand Alliance for Cardiovascular Trials (ANZACT) Network and the Australian Cardiovascular Alliance (ACVA).
Prof Reid has trained more than 30 PhD students to completion and undertaken assignments for the World Health Organization in cardiovascular disease prevention in the Asia Pacific Region.
Source: Supplied
https://orcid.org/0000-0001-9173-3944
-
Metabolic phenotyping, lipidomics & bioinformatics in dementia
Dr Luke Whiley is a dementia researcher whose work focuses on understanding how the body’s metabolism, particularly the biology of fats known as lipids, influences our health throughout ageing.
His research explores how the body responds to illness, lifestyle, and environmental stress at a chemical level, and how these responses shape longterm disease risk. Using advanced blood-based measurement technologies, Dr Whiley studies thousands of small molecules at once to build a snapshot of a person’s metabolic health. By combining these measurements with data science approaches, his work identifies biological pathways that become disrupted in disease, providing insight into why some people are more vulnerable to conditions such as dementia.
-
Applications of long-read sequencing in clinical genomics
Dr Ira Deveson is a mid-career researcher and Snow Fellow. He has expertise in clinical genomics, biotechnology development and bioinformatics, with his lab focusing on applications of long-read sequencing in clinical genomics. His work spans from computational methods development and software/hardware engineering, to large-scale genomic analysis of diverse cohorts in health and disease.
-
Post stroke brain recovery targeting blood flow and vessel health
Dr Daniel Beard is a Senior Lecturer and Group Leader of the Neurovascular Research Laboratory at the University of Newcastle, with a distinguished career in stroke research. Dr Beard completed his PhD in Human Physiology in 2015, uncovering the impact of intracranial pressure on collateral vessel failure. He has held prestigious research and teaching roles at the University of Oxford and Charité Universitätsmedizin Berlin, contributing to international collaborations on neurovascular protection. His research has been supported by competitive grants, including an NHMRC Ideas Grant, and he has received numerous awards for innovation, research excellence and teaching excellence.
